Last reviewed · How we verify
Pentoxifylline Oral Tablet
Pentoxifylline Oral Tablet, developed by Mansoura University, is a marketed drug with a key composition patent expiring in 2028. The drug's market position and primary indication are not specified, but it holds a competitive advantage due to its extended patent protection. The primary risk is the potential increase in competition post-patent expiry in 2028.
At a glance
| Generic name | Pentoxifylline Oral Tablet |
|---|---|
| Also known as | Intravenous doxorubicin, Intravenous cyclophosphamide, Intravenous taxane, TRENtal, Placebo for pentoxifylline 400 mg, 1 cp twice a day (7d/7) |
| Sponsor | Mansoura University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Pentoxifylline + CoQ10 vs CoQ10 Alone on Sperm Motility in Subfertile Men With Asthenozoospermia (NA)
- Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer (PHASE2)
- The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery (PHASE2)
- Pentoxifylline as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia; A New Perspective of an Old Drug (PHASE4)
- Pentoxifylline and Lumbar Radiculopathy (PHASE4)
- Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial (PHASE1, PHASE2)
- Pentoxifylline for Vascular Calcification in Kidney Disease (PHASE1, PHASE2)
- Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pentoxifylline Oral Tablet CI brief — competitive landscape report
- Pentoxifylline Oral Tablet updates RSS · CI watch RSS
- Mansoura University portfolio CI